Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 23 May 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2016.
- 01 Dec 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
- 27 May 2015 New trial record